Printer Friendly
The Free Library
14,558,602 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

SYNCOR DENIES DUPONT CLAIMS.


Byline: Jason Takenouchi Staff Writer

Medical firm Syncor International Corp. is firing back against counterfeiting counterfeiting, manufacturing spurious coins, paper money, or evidences of governmental obligation (e.g., bonds) in the semblance of the true. There must be sufficient resemblance to the genuine article to deceive a person using ordinary caution.  allegations filed in Mexico by DuPont Pharmaceuticals Co.

Woodland Hills-based Syncor announced Monday it has filed a defense with Mexican regulators that denies charges it purchased and sold counterfeit To falsify, deceive, or defraud. A copy or imitation of something that is intended to be taken as authentic and genuine in order to deceive another.

A counterfeit coin is one that may pass for a genuine coin and may include a lower denomination coin altered so that it may
 doses of DuPont's Cardiolite, a cardiac imaging product used to examine blood flow in the heart.

Syncor officials also took DuPont to task over the airing of the charges, which were filed June 17 but announced by DuPont last week on U.S. news wires.

``We were stunned stun  
tr.v. stunned, stun·ning, stuns
1. To daze or render senseless, by or as if by a blow.

2. To overwhelm or daze with a loud noise.

3.
 that DuPont would see the need to announce a Mexican situation here in the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area. , particularly to make what we view as false statements regarding the situation,'' said John S. Baumann, senior vice president and general counsel for Syncor.

William DeLorbe, an executive vice president at DuPont's Medical Imaging Division, said the company stands by its charges.

``DuPont does not file lawsuits capriciously ca·pri·cious  
adj.
Characterized by or subject to whim; impulsive and unpredictable. See Synonyms at arbitrary.



ca·pricious·ly adv.
,'' DeLorbe said.

The Mexican government is investigating the charges.

Both sides said the patent infringement patent infringement n. the manufacture and/or use of an invention or improvement for which someone else owns a patent issued by the government, without obtaining permission of the owner of the patent by contract, license or waiver.  suit will not affect a longstanding U.S. Cardiolite distribution agreement between Syncor and DuPont. Under that agreement, Syncor distributes more than 80 percent of the unit doses of Cardiolite in the United States, according to according to
prep.
1. As stated or indicated by; on the authority of: according to historians.

2. In keeping with: according to instructions.

3.
 Syncor officials.

Sutro & Co. analyst D. Larry Smith

For other people named Larry Smith, see Larry Smith (disambiguation).
Larry W. Smith (born 1951 in Hudson, Quebec) is a Canadian athlete and businessperson. He is currently the president of the Montreal Alouettes.
 estimated U.S. Cardiolite sales are worth about $250 million and are growing by 25 percent annually.

In contrast, Syncor's Mexican operations include just $400,000 in Cardiolite business, Baumann said.

The Mexican dispute - technically between a Syncor subsidiary and DuPont - bubbled to the surface June 17 when DuPont filed charges with the Mexican Institute of Industrial Property. The multibillion-dollar company alleged that Syncor illegally purchased and sold Cardiolite, including counterfeit Cardiolite.

Baumann, the Syncor executive, said his company has DuPont's permission to distribute unit doses of Cardiolite in Mexico, but another company, Accesorios Para Laboratories, is authorized to sell the material in bulk.

Baumann said all the Cardiolite his company sells in Mexico is purchased from either DuPont or Accesorios.

``If we acquired something that was not Cardiolite,'' Baumann said, ``it would have been from DuPont or their local distributor.''

DuPont executive DeLorbe confirmed that Syncor has permission to distribute unit doses of Cardiolite. But he said DuPont's investigation into the matter supports the counterfeiting charge.
COPYRIGHT 1999 Daily News
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1999, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:BUSINESS
Publication:Daily News (Los Angeles, CA)
Date:Jul 27, 1999
Words:382
Previous Article:UNIVERSAL'S VENUES TO BE TURNING BLUES.(BUSINESS)
Next Article:RATE FEARS WEIGH ON DOW; FED WATCHERS HOLD BREATH.(BUSINESS)
Topics:



Related Articles
Once 'Gentle' Ride Gets Wild.(Syncor International Corp.)(Brief Article)(Statistical Data Included)
FIRM ADVANCES CANCER FIGHT SYNCOR ACQUIRES DRUG FIRM, GAMMA KNIFE.(Business)
BUSINESS NOTES AMPLIFIER MAKER ACCUSED OF FRAUD.(Business)
IN BRIEF.(BUSINESS)
IMAGING FIRM GOING TO SYNCOR.(BUSINESS)
SYNCOR ENTERS BUYING DEAL.(Business)
CONTRACT LOSS HITS SYNCOR'S SHARES; STOCK DECLINES 4.5% ON NEWS.(Business)
SYNCOR SIGNS DEAL WITH AMERINET TO BE ITS SOLE SUPPLIER.(BUSINESS)
SYNCOR BOUGHT CARDINAL DRUG DEAL SUSTAINS GROWTH SPREE.(Business)(Statistical Data Included)
Syncor Inc. acquired by Cardinal Health.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles